"Hemorrhage" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bleeding or escape of blood from a vessel.
| Descriptor ID |
D006470
|
| MeSH Number(s) |
C23.550.414
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemorrhage".
Below are MeSH descriptors whose meaning is more specific than "Hemorrhage".
This graph shows the total number of publications written about "Hemorrhage" by people in this website by year, and whether "Hemorrhage" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 1 | 2 |
| 1998 | 3 | 0 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 2 | 3 |
| 2003 | 0 | 3 | 3 |
| 2004 | 3 | 4 | 7 |
| 2005 | 1 | 5 | 6 |
| 2007 | 0 | 6 | 6 |
| 2008 | 3 | 1 | 4 |
| 2009 | 5 | 2 | 7 |
| 2010 | 2 | 7 | 9 |
| 2011 | 3 | 4 | 7 |
| 2012 | 3 | 6 | 9 |
| 2013 | 5 | 6 | 11 |
| 2014 | 4 | 5 | 9 |
| 2015 | 5 | 5 | 10 |
| 2016 | 14 | 7 | 21 |
| 2017 | 7 | 5 | 12 |
| 2018 | 6 | 4 | 10 |
| 2019 | 6 | 9 | 15 |
| 2020 | 7 | 6 | 13 |
| 2021 | 6 | 7 | 13 |
| 2022 | 0 | 14 | 14 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemorrhage" by people in Profiles.
-
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials. Lancet. 2024 Sep 07; 404(10456):937-948.
-
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome. Circulation. 2024 Jul 23; 150(4):317-335.
-
Inflammatory Potential and Risk?Prediction After PCI in High?Bleeding?Risk?Patients. JACC Cardiovasc Interv. 2024 Feb 12; 17(3):356-358.
-
Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2024 Feb; 103(3):425-434.
-
Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long? Med Clin North Am. 2024 May; 108(3):539-551.
-
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous?Coronary Intervention. JACC Cardiovasc Interv. 2023 10 23; 16(20):2514-2524.
-
Bleeding and Ischemic Risks of Ticagrelor?Monotherapy After Coronary?Interventions. J Am Coll Cardiol. 2023 08 22; 82(8):687-700.
-
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation. 2023 06 20; 147(25):1933-1944.
-
Predicting functional outcomes after acute ischemic stroke - Is thrombelastography useful outside perioperative bleeding management? Thromb Res. 2023 07; 227:60-61.
-
Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2023 04 10; 9(3):240-250.